Biological, pharmaceutical, and analytical considerations with respect to the transport media used in the absorption screening system, Caco-2.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Journal of Pharmacy and Science

• Publication date

  2003-08-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1002/JPS.10408PMID 12884242
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Influence of Intestinal Mucus Components on the Diffusion of Drugs

  2004cited by this paper
• Comparison of Bidirectional Cephalexin Transport Across MDCK and Caco-2 Cell Monolayers: Interactions with Peptide Transporters

  2004cited by this paper
• Dissolution Testing as a Prognostic Tool for Oral Drug Absorption: Immediate Release Dosage Forms

  2004cited by this paper
• Transport Activity of Human MRP3 Expressed in Sf9 Cells: Comparative Studies with Rat MRP3

  2004cited by this paper
• Enhanced transport of a novel anti-HIV agent--cosalane and its congeners across human intestinal epithelial (Caco-2) cell monolayers.

  2003cited by this paper
• Optimized conditions for MDCK permeability and turbidimetric solubility studies using compounds representative of BCS classes I-IV.

  2002cited by this paper
• Biopharmaceutics Classification System: The Scientific Basis for Biowaiver Extensions

  2002cited by this paper
• Molecular properties that influence the oral bioavailability of drug candidates.

  2002cited by this paper
• Permeability of human intestinal mucosa using a continuous flow-through perfusion system

  2002cited by this paper
• Synthesis of analogs of L-valacyclovir and determination of their substrate activity for the oligopeptide transporter in Caco-2 cells.

  2002cited by this paper
• Effect of bovine serum albumin on drug permeability estimation across Caco-2 monolayers.

  2002cited by this paper
• Intestinal absorption characteristics of the low solubility thiocarboxanilide UC-781.

  2002cited by this paper
• Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers.

  2002cited by this paper
• A comparison of commonly used polyethoxylated pharmaceutical excipients on their ability to inhibit P-glycoprotein activity in vitro.

  2002cited by this paper
• Simulated intestinal fluid as transport medium in the Caco-2 cell culture model.

  2002cited by this paper
• Examination of the solubilization of drugs by bile salt micelles.

  2002cited by this paper
• Effects of poly(ethylene glycol) on efflux transporter activity in Caco-2 cell monolayers.

  2002cited by this paper
• Permeability of human intestinal mucosa using a continuous flow-through perfusion system.

  2002cited by this paper
• Contributions of saturable active secretion, passive transcellular, and paracellular diffusion to the overall transport of furosemide across adenocarcinoma (Caco-2) cells.

  2002cited by this paper
• Strategies for absorption screening in drug discovery and development.

  2001cited by this paper
• Caco-2 monolayers in experimental and theoretical predictions of drug transport.

  2001cited by this paper
• Caco-2 monolayers in experimental and theoretical predictions of drug transport1PII of original article: S0169-409X(96)00415-2. The article was originally published in Advanced Drug Delivery Reviews 22 (1996) 67–84.1

  2001cited by this paper
• Characterizing the Expression of CYP3A4 and Efflux Transporters (P-gp, MRP1, and MRP2) in CYP3A4-Transfected Caco-2 Cells After Induction with Sodium Butyrate and the Phorbol Ester 12-O-Tetradecanoylphorbol-13-Acetate

  2001cited by this paper
• Effect of common excipients on Caco-2 transport of low-permeability drugs.

  2001cited by this paper
• Profound Effect of Plasma Protein Binding on the Polarized Transport of Furosemide and Verapamil in the Caco-2 Model

  2001cited by this paper
• Permeability of lipophilic compounds in drug discovery using in-vitro human absorption model, Caco-2.

  2001cited by this paper
• Drug absorption in vitro model: filter-immobilized artificial membranes. 2. Studies of the permeability properties of lactones in Piper methysticum Forst.

  2001cited by this paper
• Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings.

  2001cited by this paper
• Cell cultures as tools in biopharmacy.

  2000cited by this paper
• Effects of Some Non‐ionic Surfactants on Transepithelial Permeability in Caco‐2 Cells

  2000cited by this paper
• Potential inhibitory effects of formulation ingredients on intestinal cytochrome P450.

  2000cited by this paper
• Prediction of drug absorption using multivariate statistics.

  2000cited by this paper
• Effect of solubilizing excipients on permeation of poorly water-soluble compounds across Caco-2 cell monolayers.

  2000cited by this paper
• A comparison of the permeation enhancement potential of simple bile salt and mixed bile salt:fatty acid micellar systems using the CaCo-2 cell culture model.

  2000cited by this paper
• Influence of P-glycoprotein on the transport and metabolism of indinavir in Caco-2 cells expressing cytochrome P-450 3A4.

  2000cited by this paper
• Region-dependent disappearance of vinblastine in rat small intestine and characterization of its P-glycoprotein-mediated efflux system.

  2000cited by this paper
• In vitro, ex vivo, and in situ intestinal absorption characteristics of the antiviral ester prodrug adefovir dipivoxil.

  2000cited by this paper
• Intestinal permeation enhancers.

  2000cited by this paper
• Caco-2 versus Caco-2/HT29-MTX co-cultured cell lines: permeabilities via diffusion, inside- and outside-directed carrier-mediated transport.

  2000cited by this paper
• Effects of sodium deoxycholate and sodium caprate on the transport of epirubicin in human intestinal epithelial Caco-2 cell layers and everted gut sacs of rats.

  2000cited by this paper
• Virtual screening of intestinal drug permeability.

  2000cited by this paper
• Optimized conditions for prediction of intestinal drug permeability using Caco-2 cells.

  2000cited by this paper
• The Influence of Donor and Reservoir Additives on Caco-2 Permeability and Secretory Transport of HIV Protease Inhibitors and Other Lipophilic Compounds

  2000cited by this paper
• Midazolam metabolism by modified Caco-2 monolayers: effects of extracellular protein binding.

  1999cited by this paper
• Transepithelial transport of bepridil in the human intestinal cell line, Caco-2, using two media, DMEMc and HBSS.

  1999cited by this paper
• Inhibition of P-glycoprotein by D-alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS).

  1999cited by this paper
• Pluronic P85 Increases Permeability of a Broad Spectrum of Drugs in Polarized BBMEC and Caco-2 Cell Monolayers

  1999cited by this paper
• Inhibition of P-Glycoprotein by D-α-Tocopheryl Polyethylene Glycol 1000 Succinate (TPGS)

  1999cited by this paper
• The Influence of Plasma Binding on Absorption/Exsorption in the Caco‐2 Model of Human Intestinal Absorption

  1999cited by this paper
• Transport and Metabolic Characterization of Caco-2 Cells Expressing CYP3A4 and CYP3A4 Plus Oxidoreductase

  1999cited by this paper
• Structural characterization of substrates for the anion exchange transporter in Caco-2 cells.

  1999cited by this paper
• Effect of molecular charge on intestinal epithelial drug transport: pH-dependent transport of cationic drugs.

  1999cited by this paper
• Gastrointestinal absorption of drugs: methods and studies

  1999cited by this paper
• Prediction of Membrane Permeability to Peptides from Calculated Dynamic Molecular Surface Properties

  1999cited by this paper
• Vitamin E-TPGS Increases Absorption Flux of an HIV Protease Inhibitor by Enhancing Its Solubility and Permeability1

  1999cited by this paper
• Prediction of the Intestinal Absorption of Endothelin Receptor Antagonists Using Three Theoretical Methods of Increasing Complexity

  1999cited by this paper
• Prediction of dissolution-absorption relationships from a dissolution/Caco-2 system.

  1999cited by this paper
• Evaluation of dynamic polar molecular surface area as predictor of drug absorption: comparison with other computational and experimental predictors.

  1998cited by this paper
• Characterization of the Regional Intestinal Kinetics of Drug Efflux in Rat and Human Intestine and in Caco-2 Cells

  1998cited by this paper
• P-glycoprotein transporters and the gastrointestinal tract: evaluation of the potential in vivo relevance of in vitro data employing talinolol as model compound.

  1998cited by this paper
• Physicochemical high throughput screening: parallel artificial membrane permeation assay in the description of passive absorption processes.

  1998cited by this paper
• Applications of the Caco-2 model in the design and development of orally active drugs: elucidation of biochemical and physical barriers posed by the intestinal epithelium

  1997cited by this paper
• Immobilized liposome chromatography of drugs for model analysis of drug-membrane interactions

  1997cited by this paper
• Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

  1997cited by this paper
• Immobilized Artificial Membranes — screens for drug membrane interactions

  1997cited by this paper
• Analysis of Drug Permeation Across Caco-2 Monolayer: Implication for Predicting In Vivo Drug Absorption

  1997cited by this paper
• Expression of enzymatically active CYP3A4 by Caco-2 cells grown on extracellular matrix-coated permeable supports in the presence of 1alpha,25-dihydroxyvitamin D3.

  1997cited by this paper
• Cultured intestinal epithelial cell models.

  1996cited by this paper
• Correlation of drug absorption with molecular surface properties.

  1996cited by this paper
• Development of a Stable Freeze-dried Formulation of Recombinant Human Interleukin-1 Receptor Antagonist

  1996cited by this paper
• Carrier-Mediated Intestinal Transport of Drugs

  1996cited by this paper
• Absorption of Cam-2445, and NK1 neurokinin receptor antagonist: in vivo, in situ, and in vitro evaluations.

  1996cited by this paper
• Development of Caco-2 Cells Expressing High Levels of cDNA-Derived Cytochrome P4503A4

  1996cited by this paper
• The Use of Surfactants to Enhance the Permeability of Peptides Through Caco-2 Cells by Inhibition of an Apically Polarized Efflux System

  1996cited by this paper
• Carrier-mediated transport and efflux mechanisms in Caco-2 cells

  1996cited by this paper
• A Correlation Between the Permeability Characteristics of a Series of Peptides Using an in Vitro Cell Culture Model (Caco-2) and Those Using an in Situ Perfused Rat Ileum Model of the Intestinal Mucosa

  1993cited by this paper
• Evidence for a polarized efflux system in CACO-2 cells capable of modulating cyclosporin A transport.

  1993cited by this paper
• A Drug Absorption Model Based on the Mucus Layer Producing Human Intestinal Goblet Cell Line HT29-H

  1993cited by this paper
• Convective Solvent Flow Across the Skin During Iontophoresis

  1993cited by this paper
• Role of desolvation energy in the nonfacilitated membrane permeability of dideoxyribose analogs of thymidine.

  1992cited by this paper
• Epithelial transport of drugs in cell culture. VII: Effects of pharmaceutical surfactant excipients and bile acids on transepithelial permeability in monolayers of human intestinal epithelial (Caco-2) cells.

  1992cited by this paper
• Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells.

  1991cited by this paper
• The Influence of Peptide Structure on Transport Across Caco-2 Cells

  1991cited by this paper
• Caco-2 Cell Monolayers as a Model for Drug Transport Across the Intestinal Mucosa

  1990cited by this paper
• Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability.

  1989cited by this paper
• In Vitro Measurement of Gastrointestinal Tissue Permeability Using a New Diffusion Cell

  1988cited by this paper
• Determination of acid surface pH in vivo in rat proximal jejunum.

  1983cited by this paper
• A practitioner's perspective of the role of quantitative structure-activity analysis in medicinal chemistry.

  1981cited by this paper

• Assessment of intestinal absorption of five cannabinoids from an ethanolic CBD-rich hemp extract using Caco-2 cells in vitro.

  2025cites this paper
• Bridging the Gap between in vitro and in vivo Solubility-Permeability Interplay.

  2024cites this paper
• Screening oral drugs for their interactions with the intestinal transportome via porcine tissue explants and machine learning

  2024cites this paper
• Combinational Inhibition of P-Glycoprotein-Mediated Etoposide Transport by Zosuquidar and Polysorbate 20

  2023cites this paper
• Challenges in Permeability Assessment for Oral Drug Product Development

  2023influential citation
• Characterization of dissolution-permeation system using hollow fiber membrane module and utility to predict in vivo drug permeation across BCS classes.

  2022cites this paper
• Current challenges and future perspectives in oral absorption research: An opinion of the UNGAP network.

  2021cites this paper
• Best practices in current models mimicking drug permeability in the gastrointestinal tract - an UNGAP review.

  2021cites this paper
• Optimizing Pharmacokinetic Property Prediction Based on Integrated Datasets and a Deep Learning Approach

  2020cites this paper
• An Openable Artificial Intestinal Tract System Enables the Evaluation of Drug Absorption in Caco-2 Cells through the Reduction in Thickness of the Unstirred Water Layer.

  2019cites this paper
• Permeability of the ellagitannin geraniin and its metabolites in a human colon adenocarcinoma Caco-2 cell culture model.

  2019cites this paper
• Permeability through Caco-2 cell monolayers as a model for BBB: implementation and preliminary evaluation using model compounds

  2019cites this paper
• Punicalagin increases glutamate absorption in differentiated Caco-2 cells by a mechanism involving gene expression regulation of an EAAT3 transporter.

  2019cites this paper
• Constructing an in silico three-class predictor of human intestinal absorption with Caco-2 permeability and dried-DMSO solubility.

  2019cites this paper
• Evaluation of biorelevant media to investigate the dissolution properties on flurbiprofen and to assess cytotoxicity effects on Caco-2 cell line

  2019influential citation
• Investigation of Intestinal Absorption Enhancers: Individual vs. Blends with the Carbamoylphosphonate JS403

  2018cites this paper
• Aqueous Solubility Enhancement for Bioassays of Insoluble Inhibitors and QSPR Analysis: A TNF-α Study

  2018cites this paper
• Using Human Plasma as an Assay Medium in Caco-2 Studies Improves Mass Balance for Lipophilic Compounds

  2018cites this paper
• Transport rates of dietary phytochemicals in cell monolayers is inversely correlated with absorption kinetics in humans

  2017cites this paper
• Applications of cell culture studies in pharmaceutical technology

  2017cites this paper
• Development of a μDissolution-Permeation model with in situ drug concentration monitoring

  2016cites this paper
• Intestinal permeability and P‐glycoprotein‐mediated efflux transport of ticagrelor in Caco‐2 monolayer cells

  2016cites this paper
• Novel in vitro transport method for screening the reversibility of P-glycoprotein inhibitors.

  2016cites this paper
• Transepithelial Transport of Curcumin in Caco-2 Cells Is significantly Enhanced by Micellar Solubilisation

  2016cites this paper
• A Sensitive Medium-Throughput Method to Predict Intestinal Absorption in Humans Using Rat Intestinal Tissue Segments.

  2015cites this paper
• Development of biomimetic phospholipid vesicle-based permeation assays (PVPA) as screening tool in drug development

  2015cites this paper
• In situ perfusion in rodents to explore intestinal drug absorption: challenges and opportunities.

  2015cites this paper
• Characterization of particulate drug delivery systems for oral delivery of Peptide and protein drugs.

  2015influential citation
• Evaluation of fasted and fed state simulated and human intestinal fluids as solvent system in the Ussing chambers model to explore food effects on intestinal permeability.

  2015cites this paper
• UNTERSUCHUNGEN ZUM EINFLUSS DES INTRAVENÖSEN ANÄSTHETIKUMS PROPOFOL AUF HYPOXIE INDUZIERTE MECHANISMEN IN-VITRO

  2014cites this paper
• Mechanistic studies and modeling of effects of ingested lipids on oral drug absorption

  2014cites this paper
• QSPR and flow cytometry analysis (QSPR-FCA): review and new findings on parallel study of multiple interactions of chemical compounds with immune cellular and molecular targets.

  2014cites this paper
• Cyclosporin A affects the bioavailability of ginkgolic acids via inhibition of P-gp and BCRP.

  2014cites this paper
• Phorbol 12-myristate 13-acetate inhibits P-glycoprotein-mediated efflux of digoxin in MDCKII-MDR1 and Caco-2 cell monolayer models

  2013cites this paper
• Identification of the Molecular Mechanisms underlying the Gastrointestinal Toxicity of the Immunosuppressants Mycophenolate Mofetil and Enteric-coated Mycophenolate Sodium using a Proteo-Metabolomic Approach

  2013cites this paper
• Biopharmaceutical profiling of a pyrido[4,3-d] pyrimidine compound library.

  2013cites this paper
• The effect of probiotic Escherichia coli strain Nissle 1917 lipopolysaccharide on the 5-aminosalicylic acid transepithelial transport across Caco-2 cell monolayers.

  2013cites this paper
• Shape effect in the design of nanowire-coated microparticles as transepithelial drug delivery devices.

  2012cites this paper
• BUFFERS FOR IN VITRO EVALUATION OF DRUG PERMEABILITY: A REVIEW

  2012cites this paper
• Carotenoids bioavailability from foods: From plant pigments to efficient biological activities

  2012cites this paper
• Oral nanocrystal formulations and their biopharmaceutical characterization

  2012influential citation
• ANN multiplexing model of drugs effect on macrophages; theoretical and flow cytometry study on the cytotoxicity of the anti-microbial drug G1 in spleen.

  2012cites this paper
• The Impact of Solubility and Dissolution Assessment on Formulation Strategy and Implications for Oral Drug Disposition

  2012cites this paper
• In vitro models to evaluate the permeability of poorly soluble drug entities: challenges and perspectives.

  2012cites this paper
• Approach to improve compound recovery in a high-throughput Caco-2 permeability assay supported by liquid chromatography-tandem mass spectrometry.

  2012cites this paper
• Técnicas de complejidad variable para evaluar la absorción de fármacos

  2012cites this paper
• Syddansk Universitet Effect of the non-ionic surfactant Poloxamer 188 on passive permeability of poorly soluble drugs across Caco-2 cell monolayers

  2011cites this paper
• Antifungal activity of redox-active benzaldehydes that target cellular antioxidation

  2011cites this paper
• Intestinal Perfusion Methods for Oral Drug Absorptions

  2011cites this paper
• Lipophilic derivatives of leu-enkephalinamide: in vitro permeability, stability and in vivo nasal delivery.

  2011cites this paper
• University of Southern Denmark Effect of the non-ionic surfactant Poloxamer 188 on passive permeability of poorly soluble drugs across Caco-2 cell monolayers Fischer, Sarah; Brandl, Martin

  2011cites this paper
• Effect of the non-ionic surfactant Poloxamer 188 on passive permeability of poorly soluble drugs across Caco-2 cell monolayers.

  2011cites this paper
• Carotenoid availability - from dietary intake to factors governing their bioavailability as studied by in vitro digestion coupled to Caco-2 cellular uptake models

  2011cites this paper
• Carotenoid availability - from dietary intake to factors governing their bioavailability as studied by in vitro digestion coupled to Caco-2 cellular uptake models

  2011cites this paper
• Novel and established intestinal cell line models – An indispensable tool in food science and nutrition

  2011cites this paper
• Intestinal transport of pure theanine and theanine in green tea extract: Green tea components inhibit theanine absorption and promote theanine excretion

  2011cites this paper
• In‐vitro permeability of poorly water soluble drugs in the phospholipid vesicle‐based permeation assay: the influence of nonionic surfactants

  2011cites this paper
• Encapsulation of Curcumin in O/w Nanoemulsions and Its Bioaccessibility After In Vitro Digestion

  2010cites this paper
• The impact of protein on Caco-2 permeability of low mass balance compounds for absorption projection and efflux substrate identification.

  2010cites this paper
• Tanshinone IIA increases mRNA expression of efflux transporters in cultured human intestinal cell.

  2010cites this paper
• Methods for Assessing Aspects of Carotenoid Bioavailability

  2010cites this paper
• Water-soluble organic solubilizers for in vitro drug delivery studies with respiratory epithelial cells: Selection based on various toxicity indicators

  2010influential citation
• Toxicity of cylindrospermopsin, and other apparent metabolites from Cylindrospermopsis raciborskii and Aphanizomenon ovalisporum, to the zebrafish (Danio rerio) embryo.

  2009cites this paper
• Transepithelial transport of ambroxol hydrochloride across human intestinal Caco-2 cell monolayers.

  2009cites this paper
• In vitro bioaccessibility assessment as a prediction tool of nutritional efficiency.

  2009cites this paper
• Modeling Kinetics of Subcellular Disposition of Chemicals

  2009cites this paper
• Absorption of 3(2H)-furanones by human intestinal epithelial Caco-2 cells.

  2009cites this paper
• Comparison of bidirectional lamivudine and zidovudine transport using MDCK, MDCK-MDR1, and Caco-2 cell monolayers.

  2009cites this paper
• Emulsion-based delivery systems for tributyrin, a potential colon cancer preventative agent.

  2009cites this paper
• DETERMINATION OF THE PERMEABILITY OF BIOLOGICAL MEMBRANES TO VARIOUS CHEMICAL MARKERS, INCLUDING ANTI-HIV DRUGS

  2009cites this paper
• Etude in vitro et in vivo de deux héparines de bas poids moléculaire microencapsulées de rapports anti-Xa/anti-IIa différents : la nadroparine et la tinzaparine

  2009cites this paper
• Chemistry, Stability, and Biological Actions of Carotenoids

  2009cites this paper
• In Vitro Screening Models to Assess Intestinal Drug Absorption and Metabolism

  2008cites this paper
• Investigation of the transport of lipophilic drugs in structurally diverse lipid formulations through caco-2 cell monolayer using mathematical modeling

  2008cites this paper
• Predicting drug disposition, absorption/elimination/transporter interplay and the role of food on drug absorption.

  2008cites this paper
• Permeability for intestinal absorption: Caco-2 assay and related issues.

  2008cites this paper
• Development of Fluorescence-Based High-Throughput Assays for Evaluation of ADME-Tox Properties in Drug Discovery

  2008cites this paper
• Use of simulated intestinal fluid for Caco-2 permeability assay of lipophilic drugs.

  2008cites this paper
• An evaluation of the relative roles of the unstirred water layer and receptor sink in limiting the in‐vitro intestinal permeability of drug compounds of varying lipophilicity

  2008cites this paper
• In Silico Methods for Unraveling the Mechanistic Complexities of Intestinal Absorption: Metabolism-Efflux Transport Interactions

  2008cites this paper
• Physical and biological considerations for the use of nonaqueous solvents in oral bioavailability enhancement.

  2008cites this paper
• Drug Absorption Studies

  2008cites this paper
• Increased paracellular absorption by bile salts and P-glycoprotein stimulated efflux of otilonium bromide in Caco-2 cells monolayers as a model of intestinal barrier.

  2008cites this paper
• Instrumented In Vitro Approaches to Assess Epithelial Permeability of Drugs from Pharmaceutical Formulations

  2008cites this paper
• An evaluation of the relative roles of the unstirred water layer and receptor sink in limiting the in-vitro intestinal permeability of drug compounds of varying lipophilicity.

  2008cites this paper
• Determination of drug absorption parameters in Caco-2 cell monolayers with a mathematical model encompassing passive diffusion, carrier-mediated efflux, non-specific binding and phase II metabolism

  2007cites this paper
• Development of simulated intestinal fluids containing nutrients as transport media in the Caco-2 cell culture model: assessment of cell viability, monolayer integrity and transport of a poorly aqueous soluble drug and a substrate of efflux mechanisms.

  2007cites this paper
• Dietary factors influencing non-heme iron absorption

  2007cites this paper
• In vitro methods to study intestinal drug metabolism.

  2007cites this paper
• Peptide transporter substrate identification during permeability screening in drug discovery: Comparison of transfected MDCK-hPepT1 cells to caco-2 cells

  2007cites this paper
• Absorption of poorly water soluble drugs subject to apical efflux using phospholipids as solubilizers in the Caco-2 cell model.

  2007cites this paper
• Advantages and disadvantages of using bovine serum albumin and/or Cremophor EL as extracellular additives during transport studies of lipophilic compounds across Caco-2 monolayers

  2007cites this paper
• Combined assessment of dissolution and epithelial permeability of solid oral dosage forms

  2007influential citation
• Selection of Solvent Systems for Membrane-, Cell- and Tissue-Based Permeability Assessment

  2007cites this paper
• Parameters influencing intestinal epithelial permeability and microparticle uptake in vitro.

  2007cites this paper
• The Use of Solubilizing Excipients and Approaches to GenerateToxicology Vehicles for Contemporary Drug Pipelines

  2007cites this paper
• University of Groningen Drug metabolism in human and rat intestine

  2007cites this paper
• Impact of cremophor-EL and polysorbate-80 on digoxin permeability across rat jejunum: delineation of thermodynamic and transporter related events using the reciprocal permeability approach.

  2007cites this paper
• Drug metabolism in human and rat intestine

  2007influential citation
• In vitro models for processes involved in intestinal absorption.

  2007cites this paper